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Oleuropein and hydroxytyrosol, as major compounds of olive leaves, have been reported to exert numerous pharmacological
properties, including anticancer, antidiabetic, and anti-inflammatory activities. +e purpose of this study is to evaluate and
compare the protective effect of oleuropein- and hydroxytyrosol-rich extracts, derived from olive leaves, on high-fat diet-induced
lipid metabolism disturbance and liver injury in rats. In this respect, four groups of male rats (8 per group) were used: control
group (Control), group treated with high-fat diet (HFD), group treated with HFD and oleuropein (HFD+OLE), and group
treated with HFD and hydroxytyrosol (HFD+HYD).+e current research showed that the treatment with the HFD increased the
body weight and adipose tissue mass in male rats. Moreover, the plasma levels of triglycerides, total cholesterol, LDL-cholesterol,
AST, ALT, LDH, and TNF-α were also raised. +e hepatic immunohistochemical analysis revealed a significant increase in the
expression of inflammatory genes (COX-2, NF-κB, and TNF-α). Equally, it showed a rise of the apoptotic markers (a decrease in
the expression of the Bcl-2 and an increase of the P53). In addition, the oral administration of oleuropein- and hydroxytyrosol-rich
olive leaf extracts at 16mg/kg similarly reduced the body weight and adipose tissuemass and improved the lipid profile. Moreover,
these extracts, mainly the hydroxytyrosol-rich extract, reduced the elevated liver enzymes, enhanced the antioxidant status, and
attenuated the liver inflammation and apoptosis. +ese findings suggest that the oleuropein- and hydroxytyrosol-rich olive leaf
extracts possessed hypolipidemic and hepatoprotective effects against the HFD-induced metabolic disorders by enhancing the
antioxidative defense system and blocking the expression of the proteins involved in inflammation and liver damage.
1. Introduction
Obesity is a serious health problem worldwide that increases
the risk factors for chronic diseases such as diabetes, car-
diovascular disease, liver dysfunction, hypertension, and
some forms of cancer [1–4]. Even though the pathophysi-
ology of obesity is complex, dietary factors, mainly the
consumption of high-fat diet, are considered as major risk
factors for its development. Consequently, it is very im-
portant to prevent obesity for a healthy life. Many different
approaches have been used to treat obesity, including diet
control, sport, behavior therapy, medications, and surgery
[5–7]. Among these therapies, change in eating habits, ex-
ercise, and behavior modification are essential to the
management of obesity. Nevertheless, their outcomes are
not often satisfactory. Various antiobesity drugs, including
orlistat, phentermine, mazindol, phendimetrazine, and
diethylpropion, have been approved by the Food and Drug
Administration. However, since these drugs have been
known for their side effects such as headaches, vomiting, and
myocardial infarctions. Orlistat is the only one approved due
to its long-term weight control [8]. Numerous researchers
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are interested in using effective natural products based on
fruits, vegetables, and herbs for the prevention and/or
treatment of obesity.
In the Mediterranean area, olive leaves are one of the by-
products of the olive grove farming. +ey can be found in
high amounts in the olive oil industries (10% of the total
weight of the olives) and they are collected during the
pruning of the olive trees [9]. +e olive leaf has been
commonly used in folk remedies as well as in human diet as
an extract, in herbal tea and in the powder form in the
Mediterranean countries [10]. Current studies have proved
that olive leaves are considered as an economical raw ma-
terial which can be regarded as a useful source for high
added value products [11].
Olive leaf extracts have drawn the attention of a number
of researchers. It is mainly due to the typical phenolic
composition linked to potent biological activities [12]. +e
major active component in olive leaves is oleuropein. After
the hydrolysis, oleuropein can produce other bioactive
substances, especially hydroxytyrosol [13]. Numerous in
vitro and in vivo studies have revealed that oleuropein and its
derivative hydroxytyrosol possess a wide range of bio-
chemical and pharmacological properties. In fact, oleur-
opein and hydroxytyrosol have previously been reported to
have antiproliferative, anti-inflammatory, antidiabetic, and
hypocholesterolemic properties [14–16].
Furthermore, several in vivo studies have demonstrated
the protective effect of hydroxytyrosol and oleuropein on
body weight gain and metabolic impairment in a rat model
of obesity [17, 18]. However, there are no researches focusing
on the comparison of the preventive role of hydroxytyrosol
and oleuropein on the development of obesity and the as-
sociated metabolic complications.
+erefore, the aim of this study was to compare the
protective effect of the oleuropein- and hydroxytyrosol-
rich extracts derived from olive leaves on the high-fat diet-
induced lipid metabolism disturbance and liver injury in
rats.
2. Materials and Methods
2.1. Oleuropein-Rich Olive Leaf Extract Preparation. Olea
europaea leaves from chemlali cultivar were collected from
the area of Sfax (Southeast of Tunisia). Olive leaves were
dried under microwaves and powdered for extraction. 100 g
of ground olive leaves were immersed in 500mL distilled
water. +e mixture was stirred at room temperature over-
night. +en it was filtered and the aqueous phase was
extracted thrice with an equal volume of ethyl acetate. After
drying the organic phase under vacuum, the residue was
lyophilized and stored until use.
2.2. Hydroxytyrosol-Rich Olive Leaf Extract Preparation.
+e olive leaves powder was extracted with a mixture of
methanol and water (4 : 1, vol/vol) overnight under agi-
tation. Next to that, the filtrate was hydrolyzed at 100°C for
1 h by using 2M HCl (4 : 1 vol/vol). +e mixture was cooled
and then extracted three times with the ethyl acetate, which
was removed by evaporation. +e residue was stored for
further analyses.
2.3. HPLC Analysis. A high performance liquid chroma-
tography analysis was performed in order to recognize and
quantify the major phenolic compounds of the olive leaf
extract. +e phenolic profile was taken following the method
of Souilem et al. [19] by using an Agilent series 1260 HPLC-
DAD instrument (Agilent Technologies, Waldbronn, Ger-
many). +e mobile phase was made of both phase A (0.1%
acetic acid in water) and phase B (100% acetonitrile). +e
elution conditions were as follows: the flow rate set at 0.5ml/
min, injection volume of 10ml, and operating temperature
of 40°C. +e running gradient was as follows: 0–22min,
10–50% B; 22–32min, 50–100% B; 32–40min, 100% B;
40–44min, 100–10% B.
Detection was conducted by a diode array detector
(DAD) while the chromatograms were recorded at
λ� 280 nm for oleuropein and hydroxytyrosol and at 330 nm
for flavonoids. +e act of quantification was carried out by
external calibration with particulars standards. +e purity
level of oleuropein and hydroxytyrosol was determined
using the LCMS/MS (Agilent 1100 LC, Germany) equip-
ment according to Bouallagui et al. [14].
2.4. Animals and Treatments. Male 10-week-old Swiss rats
weighing about 240± 10 g were obtained from the Central
Pharmacy (SIPHAT, Tunisia). All animal procedures were
conducted in accordance with the European Convention for
the protection of vertebrate animals used for experimental
and other scientific purposes (Council of Europe no. 123,
Strasbourg, 1985). +e approval of these experiments was
obtained from the Medical Ethics Committee for the Care
and Use of Laboratory Animals of the Pasteur Institute of
Tunis, Tunisia (approval number: FST/LNFP/Pro 152012).
+ey had free access to food and water for two weeks to
acclimatize them to the new environment. +e rats were
randomly divided into four groups of eight. +e first group
served as the control (CD), received normal water, standard
diet supplied by the Company of Animal Nutrition, Sfax,
Tunisia. +e second group received a high-fat diet (HFD)
(normal diet supplemented with 17% of sheep fat, 3% corn
oil, and 0.1% bile salts) (Table 1). +e third group received a
high-fat diet and treated with the oleuropein-rich olive leaf
extract (+e quantity succeeding to 16mg/kg of B.W.
oleuropein). +e fourth group received a high-fat diet and
treated with the hydroxytyrosol-rich olive leaf extract (the
quantity succeeding to 16mg/kg of B.W. hydroxytyrosol).
+e treatment with the oleuropein- and hydroxytyrosol-rich
olive leaf extracts was via oral route for 60 days.
2.5. Samples Preparation. During the experiment, the body
growth of rats was continuously monitored. After 60 days of
treatment, blood samples were collected from the brachial
artery in heparinized tubes and centrifuged at 2200g for
15min. +e liver and epididymal adipose tissue were
carefully dissected out and weighed. All the samples were
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stored at − 80°C for subsequent biochemical and histological
analyses.
2.6. Biochemical Analysis. +e plasma levels of the aspartate
aminotransferase (AST), lactate dehydrogenase (LDH), al-
anine aminotransferase (ALT), triglyceride (TG), total
cholesterol (TC), HDL-cholesterol, and glucose were mea-
sured by using an automatic biochemistry analyzer (Vita lab
Flexor E, USA) at the biochemical laboratory of the Hedi
Chaker Hospital (Sfax, Tunisia). +e plasma levels of the
TNF-α, leptin, and insulin were determined by the immu-
noassays as well as by using a commercially available ELISA
kit from BioVendor Research and Diagnostic Product. +e
insulin resistance was estimated by means of the Homeo-
stasis Model Assessment Index for Insulin Resistance
(HOMA-IR). It was done so by the following formula as
described by Cacho et al. [20]:
HOMA IR index �
[fasting glucose(mmol/L) × fasting insulin(mU/ml)]
22.5
. (1)
2.7. Liver Cytosol Extraction. 10 g of the liver sample was
homogenized in cold KCl (1.15%, pH: 7.4) supplemented
with the protease inhibitor cocktail (Sigma-Aldrich) by
using Polytron (PT2500E) homogenizer. +e homogenates
were centrifuged at 14000g and 4°C for 45min. +e
supernatants were preserved at − 80°C for further analyses.
2.8. Determination of Liver TBARS. As a marker of lipid
peroxidation, the TBARS (thiobarbituric acid-reactive
substances) concentrations were measured in the liver cy-
tosol. Briefly, 200 μl of cytosolic samples was blended with
600 μl of distilled water and 200 μl of 8.1% (w/v) SDS,
vortexed, and then incubated at room temperature for 5min.
+e mix was heated at 95°C for 1 h after the addition of
1.5ml of 20% acetic acid (pH: 3.5) and 1.5ml of 0.8% (w/v)
thiobarbituric acid (TBA). After incubation, the reaction was
cooled and 1ml of distilled water and 5ml of butanol:
pyridine (15 :1) solution were supplemented. +e mixture
was centrifuged at 1935g for 15min and the obtained
colored layer was measured at 532 nm by using the
malondialdehyde (MDA) made by the hydrolysis of 1,1,3,3-
tetramethoxypropane as standard.
2.9. Total Antioxidant Capacity of Liver. +e Trolox
equivalent antioxidant capacity (TEAC) assay measured
the reduction of the ABTS radical cation by antioxidants.
ABTS radical cation (ABTS+) was formed by reacting
7mM ABTS stock solution with 140mM potassium per-
sulfate, allowing the mixture to stand in the dark at a room
temperature for 12–16 h before use. For the current study,
the ABTS + solution was diluted with ethanol to an ab-
sorbance of 0.70 (±0.02) at 734 nm. In the reaction, 1ml of
diluted ABTS + solution was supplemented to 50 μl cytosol
samples or Trolox standard. +e mixture was incubated for
2 min in a glass cuvette at 30°C. +e decrease in absor-
bance was recorded at 734 nm. All the measurements
were executed in triplicate. +e free radical scavenging
capacity of the biological samples, calculated as inhibi-
tion percentage of ABTS+, was determined against a
Trolox standard curve prepared with different concen-
trations (40–200 μmol/l). +e results were expressed as
μM of Trolox equivalents.
2.10. Assay of Antioxidant System. Catalase (CAT) activity
was evaluated according to Aebi [21]. Briefly, 20mL of
liver homogenates was added to 1mL of 100mM H2O2 in
0.1M phosphate buffer (pH 7.0). +e H2O2 decomposition
rate was followed by measurement of the decline in ab-
sorbance at 240 nm for 1min. CAT activity was expressed
in international units (IU), that is, in mmol H2O2/min/mg
protein.
Superoxide dismutase activity (SOD) was calculated by
the method of Beauchamp and Fridovich [22]. Superoxide
radicals react with nitro blue tetrazolium (NBT) in the
presence of nicotinamide adenine dinucleotide hydrate
(NADH) and they produce formazan blue. +e SOD
eliminates the superoxide radicals and inhibits the formation
of formazan blue. +e intensity of the color is inversely
proportional to the enzyme activity. It is read at 560 nm. One
unit of enzyme activity was taken as the enzyme reaction,
which gave 50% inhibition of NBT reduction in one min in
the assay conditions. It is expressed as specific activity in
units/mg protein.
2.11. Histopathological Examination. +e liver and epidid-
ymal adipose tissues from all groups were fixed in 10%
formalin liquid, and embedded in paraffin. Embedded tis-
sues were cut by using microtome at 4 μm thickness and next
Table 1: Composition of the experimental diets.




Sheep fat — 170




Mineral mix 13.5 10
Vitamin and antioxidant 4.5 3.6
Amino acid 21 16.8
Bile salts — 1
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mounted on slides. All sections were deparaffinized and
rehydrated by submerging the slides in decreasing con-
centrations of ethanol. Subsequently, the slides were ex-
amined through hematoxylin-eosin (H&E) staining. Digital
images were obtained with an Olympus BX 51TF micro-
scope (Olympus Corporation, Tokyo, Japan).
+e volume densities of liver steatosis (Vv[steatosis,
liver]) were assessed by point counting methods as
mentioned previously [23]. Briefly, the volume densities
of hepatic steatosis were estimated with a test systemmade
up of 36 test points (PT) produced by the STEPanizer






Pp is the number of points that hit the structure, and PT is
the total test points.
+e average cross-sectional area of the adipocytes was
evaluated by stereology as the ratio between the volume
density of adipocytes (Vv[adipocyte]) and twice the nu-
merical density per area of adipocytes (QA[adipocyte]). Vv
[adipocyte] was estimated by point counting on a test
system, and QA[adipocyte] was estimated as the ratio be-
tween the number of adipocytes counted into a frame
(without hitting the “forbidden line”) and the test area of the
frame [25].
+e numerical density and mean nuclear height of
adipocytes were assessed by stereological analyses as
mentioned previously [26]. Briefly, physical dissector
pairs were selected and pairs from every fifth section were
chosen randomly. In this way approximately 15–20 sec-
tion pairs were obtained and evaluated.+e dissector pairs
were taken from the tissue at a known interval, until the
tissue sample was exhausted. Two consecutive sections
were mounted on each slide. Photographs of adjacent
sections were taken with a digital camera at a magnifi-
cation of ×400. Nuclei of adipocytes seen in the reference
section but not in the look-up section were counted. To
increase the countable particle (adipocyte cell nucleus)
number, we exchanged the role of sections in the second
step. An unbiased counting frame was placed on the
reference and the look-up sections on the screen of the PC
to perform the counting according to the dissector
counting method. +e bottom and the left hand edges of
the counting frame are considered to be the forbidden
(exclusion) lines together with the extension lines. Other
boundaries of the frame and the top-right corner were
considered to be inclusion points and any particle that hit
these lines or was located inside the frame was counted as
a dissector particle.
+e appropriate size of unbiased counting frame was
adjusted to count approximately 600 islet cells from each
sample. +e dimension of counting frame at PC screen used
in this study was 5 cm× 5 cm and the real dimension of this
counting frame (15.625×10− 5 cm2) was estimated by the
following formula:
Real dimension �




+e mean numerical density of adipocytes [Nv(adipo-





where ΣQ− adipocyte is the total number of nuclei counted
in the reference section; t is the mean section thickness
(1 μm), and A is the area of the unbiased counting frame.
+e mean nuclear height (H(nucleus)), which is a
measure of the size of nucleus that depends on the section




􏼢 􏼣 × t, (5)
where ΣQ(nucleus) is the total number of nuclei counted in
the reference section, ΣQ − (nucleus) is the total number of
dissector nuclei counted in the reference section, and t is the
mean section thickness (1 μm).
2.12. Immunohistochemistry. Liver tissues were dewaxed by
standard techniques. +e heat treatment to recover the
antigen sites was carried out. In order to quench endog-
enous peroxidases, the sections were treated with 3% hy-
drogen peroxide at room temperature. Next, the sections
were incubated for 1 h at room temperature with a blocking
solution and next with primary antibodies overnight at 4°C.
+e primary antibodies incorporated rabbit polyclonal
antibody against P53, Bcl-2, COX-2, NF-κB and TNF-α.
+e reactivity of the antibodies was detected with a
streptavidin-peroxidase histostaining-SP kit. Positive im-
munohistochemistry (IHC) stains were defined as yellow-
brown color. +e IHC staining slides were read on an
Olympus optical microscope over yellow-brown color
stains for 12 consecutive fields. +ey were scored according
to two variable factors: (1) counting the number of posi-
tively stained cells (0 �<5%; 1� 6%–25%; 2� 26%–50%;
3 � 51%–75%; and 4 � 76%–100%); and (2) scoring the
intensity of the staining (0 � absent; 1�weak; 2 �moderate;
3 � strong). +e final score was the product of (1) multi-
plying (2) for individual slides according to Li et al. [27].
+e final staining scores were expressed in the following
ways for simplicity: negative staining as 0 for (− ); incre-
mental positive staining as 1 + for (+); 2 + for (++); and
3 + for (+++), respectively [27].
2.13. Statistical Analysis. All values were presented as
means± standard deviation (mean± SD). +e data were
statistically analyzed by one-way ANOVA, followed by
Holm-Sidak post hoc test and by applying a significance level
of p< 0.05.
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3. Results
3.1. Oleuropein- and Hydroxytyrosol-Rich Olive Leaf Extract
Characterization. +e phenolic composition of olive leaf
extracts was investigated by the HPLC. Peaks were identified
by the comparison of the chromatographic retention time
and by the UV absorbance spectra of the compounds in olive
extracts with those of authentic standards. Tables 2 and 3
listed each of the identified phenolics in an eluted order.
+ese tables illustrated that oleuropein was the main
compound detected in the olive leaf extract (OLE). It rep-
resented 96.95% of the total phenols. Its concentration
attained 905.96mg/g of OLE. Nevertheless, hydroxytyrosol
was the major phenolic constituent of hydrolysate olive leaf
extract (HOLE). It represented 87.36% of the total phenols.
Its concentration reached 53.29mg/g of HOLE. Other
phenolic compounds such as apigenin-7-O-glucoside and
luteolin-7-O-glucoside were detected at lower concentra-
tions in both extracts.
3.2. Body Growth and Epididymal Fat Weight. During the
treatment period, a regular increase in body growth rate was
observed in the HFD treated rats as compared to control
group. In fact, a significant increase is noticed in the final
body weight and in the body mass index of the HFD treated
rats, respectively, by 25.43 and 50%, comparatively to the
control group. +e oral administration of the oleuropein-
and hydroxytyrosol-rich extracts reduced the body weight
gain and the body mass index of HFD-OLE and HFD-HYT
groups by (63.31%; 16.66%) and (63.60%; 16.66%), re-
spectively, as compared to the HFD treated group (Table 4).
To examine the effect of the olive leaf extracts supplement on
body fat distribution, the weights of the epididymal fat were
measured. +e relative weight of epididymal adipose tissue
was significantly larger in the HFD group than in the CD
group. Supplementation of the HFD rats with oleuropein
and hydroxytyrosol significantly decreased their epididymal
adipose tissue weight when compared with the high-fat-fed
group.
3.3. Lipid Parameters. +e results of lipid parameters
analysis are shown in Table 5. In fact, a significant increase is
found in cholesterol, triglyceride, and LDL-cholesterol levels
by 53, 169, and 146%, respectively, in the HFD-fed rats as
compared to the control group. However, the administration
of the oleuropein- and hydroxytyrosol-rich olive leaf extracts
led to a significant decrease of the plasma lipid content in
comparison to the values found in the high-fat diet fed rats
(p< 0.001). Comparing the hydroxytyrosol extract to the
oleuropein one, it was found more effective in the resto-
ration of lipids levels.
3.4. BloodGlucose, Insulin, andHOMA-IR Levels. +e effects
of the olive leaf extracts on the plasma glucose, the insulin,
and the HOMA-IR levels of rats in different groups are
shown in Figure 1. At the end of the experiment, the HFD-
fed rats exhibited a significant increase of glucose, insulin,
and HOMA-IR levels as compared to CD group. However,
the oleuropein and hydroxytyrosol groups showed lower
(p< 0.001) plasma levels of glucose, insulin, and HOMA-IR
than the HFD group. In comparison to the oleuropein
extract, the hydroxytyrosol one was more effective in the
restoration of glucose, insulin, and HOMA-IR amounts.
3.5. Plasma Levels of Liver Injury Biomarkers. As shown in
Table 6, the data illustrated a significant increase in the
plasma of AST, ALT, and the LDH levels of the HFD-fed rats
(p< 0.01). In contrast, the olive leaf extracts showed a
noticeable improvement in all these biomarkers (p< 0.01)
with a greater effect on the hydroxytyrosol-rich extract.
3.6. Liver Oxidative Stress Parameters. +e oxidative stress
was evaluated in the liver by measuring the TBARS, CAT,
and SOD levels. As it is shown in Figure 2, a high-fat diet
treatment resulted in a remarkable increase of theMDA level
(p< 0.001) associated with a significant decrease of the CAT
and the SOD activities (p< 0.0001). +e intake of the
oleuropein- and hydroxytyrosol-rich extracts in the HFD-
fed rats improved significantly (p< 0.05) the antioxidant
capacity and reduced the lipid peroxidation of liver tissue
towards the control values (Figure 2). When compared to
the oleuropein extract, the hydroxytyrosol one offers a
greater improvement of hepatic antioxidative status in HFD
rats.
3.7. PlasmaLevels of Leptin andTNF-α. Figure 3 illustrated a
significant increase in the plasma leptin and the TNF- α
levels (p< 0.01) in the HFD treated group. +e oleuropein
andmarkedly the hydroxytyrosol supplementation at 16mg/
kg showed a significant depletion in all these markers plasma
levels (p< 0.01).
3.8. Histopathological and Immunohistochemical Study of
Liver. +e histopathological analysis of the HFD-fed rats
hepatic tissue showed a steatosis and inflammatory damage.
Indeed, the hematoxylin-eosin stained sections revealed
initial signs of liver inflammation by the existence of in-
flammatory cell infiltration and a steatosis illustrated by the
lipid droplet accumulation in the cytoplasm of the hepa-
tocytes (Figure 4 and Table 7). However, the oleuropein- and
hydroxytyrosol-rich olive leaf extracts administration
Table 2: Phenolic compounds detected in olive leaf extract (OLE)
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Table 3: Phenolic compounds detected in olive leaf hydrolysate extract (OLHE) with their HPLC retention times.







Table 4: Effect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts on body growth parameters of rats. Control group (CD),
treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE) and treated group with HFD and hydroxytyrosol
(HFD+HYD).
Parameters CD HFD HFD+OLE HFD+HYD
Initial body weight (g) (8)a 235± 5 235.7± 5 246.25± 5 248.62± 5
Final body weight (g) (8) 287± 4 360± 7∗∗∗∗ 292± 2++++ 294± 5++++
Body weight gain (g) (8) 52± 2 124.7± 3∗∗∗∗ 45.75± 10++++ 45.38± 8++++
Body mass index (g/cm2) (8) 0.16± 0.01 0.24± 0.05∗∗∗∗ 0.2± 0.01++++ 0.2± 0.02++++
Relative weight of epididymal fat (mg/g BW.) (8) 4.47± 0.8 9.28± 0.9∗∗∗∗ 6.34± 0.5++++ 5.20± 0.6++++¤
aNumber of determinations. Treated (HFD) vs. Control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated (HFD+OLE, HFD+HYD) vs.
Treated (HFD): ++++p≤ 0.0001, +++p≤ 0.001, ++p≤ 0.01, +p≤ 0.05. Treated HFD+OLE vs. Treated HFD+HYD: ¤¤¤¤p≤ 0.0001, ¤¤¤p≤ 0.001, ¤¤p≤ 0.01,
¤p≤ 0.05.
Table 5: Effect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts on lipid parameters. Control group (CD), treated group
with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD and hydroxytyrosol (HFD+HYD).
Parameters CD HFD HFD+OLE HFD+HYD
TC (8)a 1.07± 0.01 1.64± 0.03∗∗∗∗ 1.22± 0.04++ 1.16± 0.02++++¤
HDL (8) 0.5± 0.05 0.22± 0.01∗∗∗∗ 0.34± 0.05++ 0.45± 0.06++++¤¤
LDL (8) 0.39± 0.05 0.96± 0.07∗∗∗∗ 0.725± 0.03++ 0.44± 0.04++++¤¤
TG (8) 0.83± 0.03 2.24± 0.05∗∗∗∗ 1.28± 0.07++++ 1.21± 0.09++++¤
aNumber of determinations. Treated (HFD) vs. control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated (HFD+OLE, HFD+HYD) vs.
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Figure 1: Eect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts on plasma glucose, insulin, and HOMA-IR levels:
control group (CD), treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD
and hydroxytyrosol (HFD+HYD). Treated (HFD) vs. Control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated
(HFD+OLE, HFD+HYD) vs. Treated (HFD): ++++p≤ 0.0001, +++p≤ 0.001, ++p≤ 0.01, +p≤ 0.05. Treated HFD+OLE vs. Treated
HFD+HYD: ¤¤¤¤p≤ 0.0001, ¤¤¤p≤ 0.001, ¤¤p≤ 0.01, ¤p≤ 0.05. (a) Glucose. (b) Insulin. (c) HOMA-IR.
Table 6: Eect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts. Liver parameters changes: relative liver weight (mg/g
B.W.); plasma levels of ALT (UI/L), AST (UI/L), PAL (UI/L), and LDH (UI/L). Control group (CD), treated group with HFD (HFD), treated
group with HFD and oleuropein (HFD+OLE), and treated group with HFD and hydroxytyrosol (HFD+HYD).
Parameters CD HFD HFD+OLE HFD+HYD
Relative liver weight (mg/g B.W) (8) 35.74± 1.5 43.09± 2∗∗∗∗ 35.19± 1.7++++ 35.53± 2.1++++
AST (UI/L) (8)a 76± 3 165.66± 5∗∗∗ 100.5± 4++ 98.66± 2++
ALT (UI/L) (8) 28± 1.5 61± 2.2∗∗∗ 37.33± 1.6++ 26.5± 1+++¤
LDH (UI/L) (8) 202.75± 5 647.87± 3.2∗∗∗∗ 333.5± 3.5+++ 270.5± 2.1++++¤¤
aNumber of determinations. Treated (HFD) vs. Control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated (HFD+OLE, HFD+HYD) vs.
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Figure 2: Continued.
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decreased the lipid accumulation and the inammation in
liver tissue, which is clearly displayed by an apparent de-
pletion of nucleus death and inammatory cells inltration
(Figure 4 and Table 7). In addition, the immunohisto-
chemical study displayed a raise in the P53, COX-2, TNF-α,
and the NF-κB expression with a decrease in the Bcl-2
expression in the HFD-fed group (Figure 5 and Table 8) with
reference to the control group. ¡e administration of the
olive leaf extracts decreased the expression of the P53, COX-
2 and TNF-α considerably. It also improved the Bcl-2
protein expression (p< 0.001) (Figure 5 and Table 8).
3.9. Histological Study of Adipose Tissue. ¡e histological
study of the adipose tissue in the HFD-fed rats showed
hypertrophy of the majority of the adipocytes with mem-
brane rupture. Indeed, an increase in the adipocyte surface
area with a decrease in adipocyte number as compared to the
control groups (p< 0.001), were detected in HFD-fed rats
(Figure 6). ¡e supplementation of the oleuropein- and
hydroxytyrosol-rich olive leaf extracts (Figure 6) revealed
obvious protection of the adipose tissue aspect, which is
conrmed by a decrease in the surface area of the majority of
the adipocyte and an increase in these numbers with ref-
erence to the HFD-fed rats (p< 0.001).
4. Discussion
Researches of the new natural compounds addressing the




































CD HFD HFD + OLE HFD + HYD
(b)
Figure 3: Eect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts on the plasma leptin and TNF-α levels: control group
(CD), treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD and
hydroxytyrosol (HFD+HYD). Treated (HFD) vs. Control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated (HFD+OLE,
HFD+HYD) vs. Treated (HFD): ++++p≤ 0.0001, +++p≤ 0.001, ++p≤ 0.01, +p≤ 0.05. Treated HFD+OLE vs. Treated HFD+HYD:















































CD HFD HFD + OLE HFD + HYD
(d)
Figure 2: Eect of HFD and oleuropein- and hydroxytyrosol-rich olive leaf extracts on total antioxidant capacity, lipid peroxidation, and on
antioxidant status: catalase (CAT) and superoxide dismutase (SOD). Control group (CD), treated group with HFD (HFD), treated group
with HFD and oleuropein (HFD+OLE), and treated group with HFD and hydroxytyrosol (HFD+HYD). Treated (HFD) vs. Control (CD):
∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated (HFD+OLE, HFD+HYD) vs. Treated (HFD): ++++p≤ 0.0001, +++p≤ 0.001,
++p≤ 0.01, +p≤ 0.05. Treated HFD+OLE vs. Treated HFD+HYD: ¤¤¤¤p≤ 0.0001, ¤¤¤p≤ 0.001, ¤¤p≤ 0.01, ¤p≤ 0.05. (a) MDA. (b) ABTS. (c)
Catalase. (d) SOD.
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compared with the conventional pharmacological agents. In
this study, the comparative eect of the oleuropein- and
hydroxytyrosol-rich extracts derived from olive leaves to
modulate lipid metabolism disturbance and liver injury in
rats fed with a high-fat diet was reported.
¡e present data showed that the administration of the
oleuropein- and hydroxytyrosol-rich olive leaf extracts
identically reduced the body weight, the weight gain, and the
epididymal fat accumulation. ¡e biologic events leading to
obesity are characterized by excessive growth of the adipose
tissue resulting from an increase in the number and/or size
of adipocytes [28]. ¡e current histological study of the
epididymal adipose tissue showed that the oleuropein- and
hydroxytyrosol-rich extracts supplemented rats displayed a
signicant reduction in the adipocyte size in comparison to
the HFD-fed rats. ¡is result implies that the reduction of
the body weight after the administration of the olive leaf
phenolics is conrmed by an improvement in the histo-
logical feature of the HFD-induced adipocyte hypertrophy.
Since the adipocyte size was reduced and the cumulative
energy intake did not dier between the HFD and
HFD+OLE or HFD+HYD groups, it is highly likely to

























CD HFD HFD + OLE HFD + HYD
(b)
Figure 4: Histological aspect (a) and volume densities (Vv) of steatosis (b) of livers of dierent groups. Control group (CD), treated group
with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD and hydroxytyrosol (HFD+HYD).
Table 7: Incidence of histopathological lesions in the liver tissue of the studied groups. Injury scores: None (0), Mild (1), Moderate (2), and
Severe (3). Control group (CD), treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group
with HFD and hydroxytyrosol (HFD+HYD).
Liver lesions CD HFD HFD+OL HFD+Hyd
Portal inammation 0 2 1 1
Degeneration of hepatocytes 0 2 1 1
Vascular congestion 0 1 0 0
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hypothesize that the fat-pad weight lowering eect of
oleuropein and hydroxytyrosol could be mediated by the
inhibition of the adipogenesis [29, 30].
Moreover, along with the body weight and the adipose
mass gains, the HFD-fed rats in the present study displayed
increased plasma leptin, which enhanced the fat mass and
promoted the cholesterol ester synthesis in the macrophages
in a hyperglycemic environment [31]. ¡e increase of the
leptin concentration may function as an acute proin-
ammatory response to prevent excessive cellular stress,
which was conrmed by the augmented TNF-α level in the
HFD-fed rats. In this investigation, it was found that the
oleuropein- and hydroxytyrosol-rich olive leaf extracts
supplement reduced the serum leptin signicant levels in
line with the inammation markers. It was a suggestion of
the benecial eects of the olive leaf phenolics against the
inammation associated with obesity.
When compared to the oleuropein extract, the
hydroxytyrosol one oers greater improvement of the leptin
and the TNF-α levels.
Obesity is well-known by its accompaniment with the
alteration in blood lipid proles such as elevated TG, TC,
LDL-C levels which lead directly to liver damage [32]. ¡e
present results revealed high levels of TG, TC, and LDL-C






Figure 5: Immunohistochemical staining with anti- TNF-α, NF-κb, P53, Bcl-2, and COX-2 in the liver tissues of HFD treated rats (400x).
Control group (CD), treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD
and hydroxytyrosol (HFD+HYD).
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and lowHDL-C level in the HFD treated rats particularly if it
is compared to the control group. +e supplementation of
the HFD rats with the oleuropein- and hydroxytyrosol-rich
olive leaf extracts improved the circulating parameters re-
lated to dyslipidemia. However, the hydroxytyrosol treat-
ment is more beneficial for reducing the LDL-C level and
increasing the HDL-C level than the oleuropein adminis-
tration. +is result suggested that the olive leaf phenolic
compounds extracts exert their hypolipidemic effect on the
HFD treated rats by modeling the lipid metabolism. +ese
findings are consistent with the earlier studies indicating the
hypolipidemic effect of the olive leaf phenolics in high-fat
and high-cholesterol diet rats [16, 30].
+e association of obesity with type 2 diabetes has been
known for decades. +e ability of obesity to produce insulin
resistance represents the major basis for this link [33]. In-
sulin resistance does not only play an important patho-
physiological role in the development of type 2 diabetes, but
it also takes part as a common component of the metabolic
abnormalities, which leads to coronary heart disease, hy-
perlipidemia, and hypertension [34]. Our study demon-
strated that the oleuropein and the hydroxytyrosol-rich
extract supplementation lowered the serum insulin activity
markedly and improved the insulin sensitivity in the HFD-
fed rats. When it is compared to the oleuropein extract, it
was found that the hydroxytyrosol extract was more effective
in the restoration of the glucose, insulin, and the HOMA-IR
amounts. +ese results were consistent with the previous
report of Wang et al. [35] who showed that the olive phe-
nolics had the potential to improve the HFD-induced insulin
resistance in mice.
Nonalcoholic fatty liver diseases (NAFLD) constitute the
main common cause of chronic liver disease provoked by
obesity [36]. +e main characteristics of NAFLD are the
abnormal fat accumulation in hepatocytes and the inflam-
matory evolution to steatohepatitis [37]. In this study, the
consumption of the HFD caused a significant increase in the
relative weight of the liver and the serum AST and ALT
levels. It was suggested that the hepatic triglycerides accu-
mulation has occurred in response to the augmented influx
of the fatty acids from the adipose tissue to the liver and from
the improved endogenous fatty acids synthesis [38]. Indeed,
the microscopic examination of HFD rats liver section
revealed vacuolated hepatocytes, inflammatory cellular in-
filtration, pyknotic nuclei, and apoptosis. Previous studies
reported that the HFD promotes lipid accumulation in
hepatocytes and causes cell infiltration and necrosis [39].
Several reports demonstrated that the elevated liver enzymes
Table 8: Scoring criteria of immunohistochemistry (IHC) assay with specific antibodies used in this study. Control group (CD), treated
group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group with HFD and hydroxytyrosol
(HFD+HYD).
Staining positive cells Staining intensity Final score product
Groups Percent% Score 1 Intensity Score 2 Score 1× score 2 Score 3
NFK-B
CD <5 0 Absent 0 0-1 0(− )
HFD 51–75 3 Strong 3 9–12 3+(+++)
HFD+OL 6–25 1 Weak 1 2–4 1+(+)
HFD+Hyd 6–25 1 Weak 1 2–4 1+(+)
TNF-α
CD <5 0 Absent 0 0-1 0(− )
HFD 51–75 3 Strong 3 9–12 3+(+++)
HFD+OL 6–25 1 Weak 1 2–4 1+(+)
HFD+Hyd 6–25 1 Weak 1 2–4 1+(+)
P53
CD <5 0 Absent 0 0-1 0(− )
HFD 51–75 3 Strong 3 9–12 3+(+++)
HFD+OL 26–50 2 Moderate 2 5–8 2+(++)
HFD+Hyd 26–50 2 Moderate 2 5–8 2+(++)
Bcl-2
CD 51–75 3 Strong 3 9–12 3+(+++)
HFD 6–25 1 Weak 1 2–4 1+(+)
HFD+OL 26–50 2 Moderate 2 5–8 2+(++)
HFD+Hyd 26–50 2 Moderate 2 5–8 2+(++)
COX-2
CD <5 0 Absent 0 0-1 0(− )
HFD 51–75 3 Strong 3 9–12 3+(+++)
HFD+OL 6–25 1 Weak 1 2–4 1+(+)
HFD+Hyd 6–25 1 Weak 1 2–4 1+(+)
Note: scoring results are based on screening 12 consecutive microscopic fields. Percent positive cells (score 1) multiply staining intensity (score 2) equals final
product score (score 3). Either 0 or (− ) depicts negative staining. For example, an individual slide had <5% of staining cells (�0) with a staining intensity of 1
(�weak) which would generate a final product score of 0×1� 0; another slide had 80% of staining cells (�4) with a staining intensity of 3 (�strong) which
would give a final product score of 4× 3�12 (3+).
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ASTand ALT indicate the cellular leakage and the loss of the
functional integrity of the hepatocyte membrane architec-
ture. ¡ese two enzymes are considered as suitable markers
for liver inammation and necrosis. ¡e current results
disclosed that the administration of the oleuropein- and
hydroxytyrosol-rich olive leaf extracts ameliorated e¨-
ciently the deleterious eects of the HFD on the histo-
pathological and the biochemical events as evidenced by a
signicant reduction in the relative liver weight and the
activities of AST, ALT, and LDH. However, the hydrox-
ytyrosol supplementation is more benecial for the recovery
of the liver function than oleuropein treatment.
¡e oxidative stress plays a pivotal role in the devel-
opment of the NAFLD, particularly in the progression from
the steatosis to the steatohepatitis [40]. It is plausible that the
high levels of saturated fatty acids and hyperglycemia can
encourage a greater activation of the NADPH oxidase, in
addition to a lower formation of the antioxidant enzymes.
Accordingly, they led to an imbalance between the reactive
oxygen species formation and the antioxidant protection
featuring oxidative stress [41]. Mitochondria constantly
exposed to the high levels of the reactive oxygen species
(ROS) can suer from structural and functional alterations.
¡ey may contribute to the reduction of the beta-oxidation
leading to a greater accumulation of free fatty acid [42]. In
the present study, the exposure to the HFD-induced an
increase of the lipid peroxidation and conversely a decrease
in the total antioxidant capacity. ¡e latter is associated with
a decrease in the activity of the antioxidant liver enzyme
activity such as CAT and SOD. ¡e oleuropein- and
hydroxytyrosol-rich olive leaf extracts could diminish the
oxidative stress through lowering the MDA levels and ele-
vating the antioxidant enzyme activities in the HFD-fed rats.
However, the hydroxytyrosol extract oers greater im-
provement of the hepatic antioxidative status in the HFD
rats, in case it is compared to the oleuropein extract.
¡ese nding are in an agreement with the study of
Pirozzi et al. [43] who demonstrated that the hep-
atoprotective eects of hydroxytyrosol in the HFD animal
model were mediated through the improvement of the
mitochondrial function as well as the decrease of the oxi-
dative stress via the activation of the AMPK pathway.
Pathological increases in oxidative stress linked with the
apoptosis of the hepatic cells have emerged as an important
mechanism applied with the development and the pro-
gression of the NAFLD. ¡e apoptosis of the hepatocyte is a
characteristic of the NAFLD. It has been reported in both
patients and experimental animals [44]. It counts as one of
the possible mechanisms of the oxidative stress inducing the
hepatocyte transition from fatty liver to steatohepatitis.
Targeting the hepatocyte apoptosis could be e¨cient in
modulating the NAFLD [45]. In this investigation, the
immunohistochemical data of the liver damage induced by
the HFD showed an increase in the expression of the P53





















































Figure 6: microscopic examination of adipose tissue. Stereological analysis of adipocyte surface area (μm2) and number from control and
treated rats. Control group (CD), treated group with HFD (HFD), treated group with HFD and oleuropein (HFD+OLE), and treated group
with HFD and hydroxytyrosol (HFD+HYD). Treated (HFD) vs. Control (CD): ∗∗∗∗p≤ 0.0001, ∗∗∗p≤ 0.001, ∗∗p≤ 0.01, ∗p≤ 0.05. Treated
(HFD+OLE, HFD+HYD) vs. Treated (HFD): ++++p≤ 0.0001, +++p≤ 0.001, ++p≤ 0.01, +p≤ 0.05. Treated HFD+OLE vs. Treated
HFD+HYD: ¤¤¤¤p≤ 0.0001, ¤¤¤p≤ 0.001, ¤¤p≤ 0.01, ¤p≤ 0.05.
12 BioMed Research International
coupled with a decrease in the expression of the Bcl-2. +is
finding is in agreement with the report of Jiang et al. [46]
who showed the raise of the expression of caspase-3 and
cytochrome c in the hepatic cells of rats fed with high-fat diet
for a range from 12 to 16 weeks. +e administration of
oleuropein and hydroxytyrosol protected the liver tissue
from apoptosis mainly by the decrease in the expression of
the P53 coupled with an increase in the expression of the Bcl-
2. Similar to the current results are several studies which
have reported the antiapoptotic effects of the olive leaf
phenolics. In this respect, the oleuropein- and hydrox-
ytyrosol-rich olive leaf extracts have been demonstrated to
attenuate the liver apoptosis and the lipid metabolism dis-
turbance in the HFD-fed rats [47]. In addition, the pre-
ventive effect of hydroxytyrosol against the HFD-induced
liver damage and mitochondrial dysfunction in the obese
mice has been revealed [48]. Furthermore, Alhaithloul et al.
[49] have illustrated that olive leaf extract inhibited the
cyclophosphamide-induced oxidative stress and the apo-
ptosis in rat kidney.
Inflammation is also known as an important mediator in
the progression from the NAFLD to the NASH. +e hepatic
inflammatory response is mediated by the proinflammatory
cytokines, particularly the TNF-α, which is one of the first
adipokines released in many types of liver injury. It mod-
ulates the effects of the other cytokines. Previous data have
illustrated a significant correlation between the HFD and the
inflammatory markers such as the IL-6 and the TNF-α.
Moreover, the nuclear factor kappa B (NF-κB) plays a major
role in regulating the immune response to the inflammatory
mediators. In the immunohistochemical study, it was shown
that the treatment with the HFD increases the expression of
the COX-2, NF-κB, and TNF-α significantly in relation to
the untreated control. Our findings are in agreement with
the study of Roh et al. who demonstrated an increase of the
mRNA levels of the TNF-α, CD68, and MCP-1 in the liver of
the HFD mice [50]. Equally, it was shown that oleuropein
and hydroxytyrosol repressed the liver inflammation and
downregulated the expression of the COX-2, TNF-α, and
NF-κB. +is result went with those of Potocnjak and col-
laborators [51]. +ey showed that the oral administration of
oleuropein diminished the expression of the NF-κB, TNF-α,
and COX-2 in the kidneys upon the cisplatin treatment. In
the same case, Silva et al. [52] have demonstrated that the
hydroxytyrosol supplemented refined olive oil showed anti-
inflammatory mechanism which inhibited the iNOS and the
COX-2 expression, in the animal models of the acute in-
flammation and the rheumatoid arthritis.
5. Conclusion
+is study was an evaluation of the protective effect of the
oleuropein- and hydroxytyrosol-rich olive leaf extracts on
high-fat diet-induced lipid metabolism disturbance and liver
injury in rats. Both extracts, mainly the hydroxytyrosol-rich
extract, were strongly effective in the protection against body
weight gain by preventing the white adipose tissue over-
growth. In addition, these extracts were capable of protec-
tion against the lipid metabolism perturbation and the
degenerative changes in the hepatic cells induced by the
HFD, not only by enhancing the antioxidant system activity
in the cells but also by blocking the expression of the proteins
involved in the inflammation and liver damage.
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